• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Study exploring syphilis infections among US adults published in American Journal of Preventative Medicine

Study exploring syphilis infections among US adults published in American Journal of Preventative Medicine

by Truveta staff | Apr 15, 2025 | Research, Research Insights

Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2017 and October 2024. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
Trends in the incidence of syphilis among US adults since 2019

Trends in the incidence of syphilis among US adults since 2019

by Truveta staff | Apr 8, 2024 | Research

Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2019 to December 2023. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
Exploring birth rates and STI diagnoses during periods of high COVID-19 rates

Exploring birth rates and STI diagnoses during periods of high COVID-19 rates

by Truveta Research | May 23, 2022 | Research, Research Insights

The COVID-19 pandemic affected every aspect of many of our lives. For some, it affected how we work, where we work, who we interact with, and the frequency at which we interact with others. As we thought about the various impacts of social distancing, we were curious...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice